Étienne Chatelut

机构：Université Toulouse III - Paul Sabatier, Inserm, Centre de Recherches en Cancérologie de Toulouse, Institut universitaire du cancer de Toulouse Oncopole, Institut Claudius Regaud, UniCancer Group, Université de Toulouse · ORCID：0000-0002-7740-9096

发表论文 358 篇 · 总被引 9249 次 · h-index 51

代表论文

Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs (2023 · ESMO Open · 被引 14)
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer (2023 · Cancers · 被引 12)
Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer (2023 · Cancer Chemotherapy and Pharmacology · 被引 11)
Considering the Oral Bioavailability of Protein Kinase Inhibitors: Essential in Assessing the Extent of Drug–Drug Interaction and Improving Clinical Practice (2023 · Clinical Pharmacokinetics · 被引 11)
Digital pharmacological twins: Bridging multi-scale modelling and artificial intelligence for precision medicine: The DIGPHAT consortium (2025 · Therapies · 被引 9)
Anticorps monoclonaux conjugués et bispécifiques en cancérologie – compte rendu de la Journée de Saint Louis 2022 (2023 · Bulletin du Cancer · 被引 7)